Pfizer sees about $15bn in 2021 sales from Covid-19 vaccine

Pfizer Inc on Tuesday forecast sales of about $15 billion from the coronavirus vaccine that it is making along with German partner BioNTech.

The company said it expects total 2021 revenue of between $59.4 billion and $61.4 billion.

The vaccine was among the first to be authorised for emergency use in the United States and several other countries, and analysts have forecast billions in sales. In the fourth quarter, the vaccine brought in sales of $154 million, below expectation of $462 million, according to consensus estimates compiled by brokerage Mizuho.

The company now expects full-year adjusted earnings of $3.10 to $3.20 per share, up from its prior forecast of $3 to $3.10 per share.

- Advertisement -


  1. I’ll tell you my story of Coid19 Vaccine free at the AKUH Karachi where I’ve been for my annual Flu Vaccine shot. On my way to Vaccine corridor I noticed a young lady, boy standing with a pamphlet inviting for free Covid19 Vaccine instead of paid vaccine of Flu.
    On my asking for the disclaimer/question for liability in the event of wrong/death they answered they claimed payment for AKUH stand/table for handsome un-disclosed amount to the local enterprise to the Chinese company. The Mortality rate in Pakistan was zero.
    May I suggest to Pfizer the global company to benefit from Pakistan not to charge for trail to Pakistan as they have grauated from many companies.
    Hence Pfizer please do it under CSR. They will nurture.

Comments are closed.

- Advertisement -

Must Read

Suzuki announces plant closure and price reduction

LAHORE: Pak-Suzuki Motor Company (PSMC) has announced both a temporary shutdown of its car plant and a downward revision of its prices across its...